# Bausch + Lomb invests in Sanoculis and signs European distribution deal

Bausch + Lomb has made an equity investment in Sanoculis and signed an exclusive European distribution agreement for the MIMS® minimally invasive glaucoma treatment.

- Type: Partnership
- Announced: 2022-07-28
- Status: announced
- Products: MIMS® glaucoma treatment
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Bausch + Lomb](https://endata.com/companies/8199.md) (partner)
- [Sanoculis](https://endata.com/companies/64417.md) (partner)

## Sources

- [stocktitan.net](https://www.stocktitan.net/news/BLCO/bausch-lomb-and-sanoculis-announce-strategic-agreements-designed-to-doynhj0oeh9d.html), 2022-07-28: "Bausch + Lomb has made an equity investment in Sanoculis and signed an exclusive European distribution agreement for the MIMS® glaucoma treatment."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.